Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Perinatol ; 40(13): 1484-1494, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-35709724

RESUMO

OBJECTIVE: The aim of the study is to compare rates of prenatal care utilization before and after implementation of a telehealth-supplemented prenatal care model due to the coronavirus disease 2019 (COVID-19) pandemic. STUDY DESIGN: Using electronic medical record data, we identified two cohorts of pregnant persons that initiated prenatal care prior to and during the COVID-19 pandemic following the implementation of telehealth (from March 1, 2019 through August 31, 2019, and from March 1, 2020, through August 31, 2020, respectively) at Grady Memorial Hospital. We used Pearson's Chi-square and two-tailed t-tests to compare rates of prenatal care utilization, antenatal screening and immunizations, emergency department and obstetric triage visits, and pregnancy complications for the prepandemic versus pandemic-exposed cohorts. RESULTS: We identified 1,758 pregnant patients; 965 entered prenatal care prior to the COVID-19 pandemic and 793 entered during the pandemic. Patients in the pandemic-exposed cohort were more likely to initiate prenatal care in the first trimester (46.1 vs. 39.0%, p = 0.01), be screened for gestational diabetes (74.4 vs. 67.0%, p <0.001), and receive dating and anatomy ultrasounds (17.8 vs. 13.0%, p = 0.006 and 56.9 vs. 47.3%, p <0.001, respectively) compared with patients in the prepandemic cohort. There was no difference in mean number of prenatal care visits between the two groups (6.9 vs. 7.1, p = 0.18). Approximately 41% of patients in the pandemic-exposed cohort had one or more telehealth visits. The proportion of patients with one or more emergency department visits was higher in the pandemic-exposed cohort than the prepandemic cohort (32.8 vs. 12.3%, p < 0.001). Increases in rates of labor induction were also observed among the pandemic-exposed cohort (47.1 vs. 38.2%, p <0.001). CONCLUSION: Rates of prenatal care utilization were similar before and during the COVID-19 pandemic. However, pregnant persons receiving prenatal care during the pandemic entered care earlier and had higher utilization of certain antenatal screening services than those receiving prenatal care prior to the pandemic. KEY POINTS: · Patients initiated prenatal care earlier during the COVID-19 pandemic.. · Uptake of telehealth services was low.. · Rates of diabetes screening and ultrasound use increased during the pandemic..


Assuntos
COVID-19 , Telemedicina , Humanos , Gravidez , Feminino , COVID-19/epidemiologia , COVID-19/prevenção & controle , Cuidado Pré-Natal , Pandemias/prevenção & controle , Diagnóstico Pré-Natal , Hospitais Públicos
2.
Womens Health Issues ; 33(1): 10-16, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36117075

RESUMO

INTRODUCTION: In response to the COVID-19 pandemic, health systems quickly implemented changes in care delivery with a goal of balancing patient-focused obstetric care with the need to protect pregnant persons and health care providers from infection. Yet, there is no consensus within the scientific community on the impact these measures have on obstetric outcomes in vulnerable populations. We aimed to assess the impact of the COVID-19 pandemic on rates of obstetric procedures and severe maternal morbidity (SMM) among births at an urban safety net institution. METHODS: We used an interrupted time series design to calculate risk ratios (RRs) and 95% confidence intervals (CIs) comparing monthly rates of labor induction, cesarean births (overall and among nulliparous, term, singleton, vertex births), operative vaginal births, and SMM among births occurring at a public hospital before (March 1, 2016, to February 29, 2020) and during (March 1, 2020, to May 31, 2021) the COVID-19 pandemic. RESULTS: There were 10,714 and 2,736 births in the prepandemic and postpandemic periods, respectively. Overall, the rates of obstetric interventions and SMM were constant over the two time periods. There were no significant differences in rates of labor induction (42% during prepandemic period vs. 45% during pandemic period; RR, 1.12; 95% CI, 0.93-1.34), operative vaginal births (5% vs. 6%; RR, 1.24; 95% CI, 0.88-1.76), cesarean births (28% vs. 33%; RR, 1.10; 95% CI, 0.94-1.28), or nulliparous, term, singleton, vertex cesarean births (24% vs. 31%; RR, 1.27; 95% CI, 0.92-1.74). Rates of SMM (7% vs. 8%; RR, 1.19; 95% CI, 0.86-1.65) were also unchanged. CONCLUSIONS: Our findings indicate that the rapid implementation of measures to reduce viral transmission in the labor and delivery setting did not materially affect routine clinical management or rates of serious maternal complications.


Assuntos
COVID-19 , Pandemias , Gravidez , Feminino , Humanos , COVID-19/epidemiologia , Cesárea , Trabalho de Parto Induzido , Hospitais Públicos , Parto Obstétrico/métodos
3.
Womens Health Issues ; 32(6): 607-614, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35835642

RESUMO

INTRODUCTION: Multimorbidity, the presence of two or more chronic disease diagnoses, is associated with an increased risk of mortality and high health care costs in the general population and older adults. However, little evidence is available about the prevalence and impact of multimorbidity in obstetric populations. The goal of this analysis was to estimate the association between multimorbidity and severe maternal morbidity (SMM) and 90-day postpartum readmission in an obstetric cohort in Atlanta, Georgia. STUDY DESIGN: We conducted a retrospective cohort study of livebirths and stillbirths at Grady Memorial Hospital, from October 2015 to April 2021. To determine preexisting chronic conditions, we linked information on births to inpatient diagnoses within the prior year. Multimorbidity was defined as the presence of two or more chronic disease diagnoses at birth or within the prior year. We conducted multivariable log binomial regression to estimate risk ratios and 95% confidence intervals for the crude and adjusted (for age, race/ethnicity, parity, and insurance) association between multimorbidity (two or more chronic conditions vs. zero or one) and SMM (at or within 42 days after birth) or 90-day postpartum readmission for any reason. RESULTS: Of 14,225 included births, 10.1% were to patients with multimorbidity. Overall, SMM complicated 7.5% of births, and the 90-day readmission rate was 2.4%. Both SMM and readmission were more common among women with multimorbidity (SMM, 18.6% among women with multimorbidity compared with 6.3% without; 90-day readmission, 5.4% compared with 2.1%). Adjusting for potential confounders, multimorbidity was associated with increased risk of SMM (adjusted risk ratio, 2.9; 95% confidence interval, 2.5-3.0) and readmission (adjusted risk ratio, 2.2; 95% confidence interval, 1.7-2.9). CONCLUSIONS: Individuals entering pregnancy with two or more chronic diseases were at an increased risk of SMM and postpartum readmission compared with individuals with one or zero chronic disease diagnoses.


Assuntos
Multimorbidade , Readmissão do Paciente , Gravidez , Recém-Nascido , Humanos , Feminino , Idoso , Estudos Retrospectivos , Período Pós-Parto , Paridade
4.
Clin Obstet Gynecol ; 56(1): 166-72, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23370170

RESUMO

The drug abusing patient can provide a management dilemma for health care providers including nurses, obstetrician, anesthesiologist, and pediatrician. Certain illicit drugs may mimic other diseases of pregnancy and result in inappropriate treatment for the mother and child. Pain management may be challenging in such patients because of increasing drug tolerance and increased sensitivity to pain. This article highlights the clinical presentation in a pregnant patient who may have recently used some of the more commonly abused drugs. The ability to identify such a patient is crucial so that the appropriate screening and treatment can occur.


Assuntos
Trabalho de Parto , Complicações na Gravidez/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Anfetaminas/efeitos adversos , Cocaína/efeitos adversos , Etanol/efeitos adversos , Feminino , Humanos , Abuso de Inalantes/complicações , Transtornos Relacionados ao Uso de Opioides/complicações , Manejo da Dor , Gravidez , Oxibato de Sódio/efeitos adversos
5.
Clin Obstet Gynecol ; 53(2): 337-44, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20436309

RESUMO

The diagnosis of pulmonary disorders associated with pregnancy is complicated by concerns about maternal/fetal radiation exposure, administration of contrast media, and medicolegal issues. This article reviews diagnostic imaging modalities, radiation exposure policy statements and provides a brief review of radiographic findings in selected pulmonary disorders associated with pregnancy. Clinicians should familiarize themselves with the benefit/risk of imaging modalities. Institution-specific imaging algorithms that minimize maternal/fetal radiation exposure are recommended. Institutional system-wide protocols would minimize confusion among healthcare providers.


Assuntos
Feto/efeitos da radiação , Pneumopatias/diagnóstico por imagem , Complicações na Gravidez/diagnóstico por imagem , Angiografia , Feminino , Humanos , Gravidez , Doses de Radiação , Cintilografia , Fatores de Risco , Tomografia Computadorizada por Raios X/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...